Impact of vitamin D supplementation on markers of bone mineral metabolism in term infants

25-Hydroxyvitamin D (25OHD) may influence bone turnover. We compared the dynamics of bone markers in 30 infants on vitamin D supplementation (? 550 IU/day) with different degrees of hypovitaminosis D (25OHD < 11 ng/ml — deficiency vs. ≥ 11 < 20 ng/ml — insufficiency). Baseline and follow-up (after 10 weeks), 25OHD, 1,25-dihydroxyvitamin D (1,25(OH)₂D), alkaline phosphatase (ALP), PTH, osteocalcin (OC), N-terminal propeptide of type I procollagen (PINP), C-terminal telopeptide of type I collagen (CTX), and amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) were measured. None of the newborns had craniotabes, hypocalcemia or hyperparathyroidism. The median (Q1;Q3) 25OHD increased from a baseline of 8.45 (7;11.9) ng/ml to 54.6 (34.7;67.3) ng/ml (p < 0.001). The baseline 25OHD negatively correlated with total increment of 25OHD (r = ? 0.54; p = 0.002). There were changes in ALP (241 vs. 331 IU; p < 0.001), 1,25(OH)₂D (48 vs. 95.5 pg/ml, p < 0.001), OC (88.8 vs. 159.1 ng/ml, p < 0.001), PINP (3886 vs. 2409 ng/ml; p < 0.001), CTX (1.6 vs. 1.1 ng/ml; p < 0.001), and NT-proCNP (75.1 vs. 35.1 pmol/l; p < 0.001). Vitamin D deficient infants at baseline, compared to the insufficient group, revealed significantly higher percentage changes for 25OHD (745% vs. 167%, p < 0.0001), OC (113% vs. 40%, p < 0.05) and 1,25(OH)₂D (95% vs. 58%, p < 0.05). Conclusions: Vitamin D supplements had little to no impact on markers of bone turnover in term infants in the first few months of life, with the exception of osteocalcin. Ten weeks of cholecalciferol supplementation at a dose of 550 IU/day led to a marked increase of 25OHD concentration. The magnitude of 25OHD increment was inversely related to vitamin D status at baseline. Irrespective of the severity of vitamin D deficiency, a secondary hyperparathyroidism with elevated iPTH, ALP, phosphaturia or hypophosphatemia was not observed in the studied neonates.